Van Eck Associates Corp Intellia Therapeutics, Inc. Transaction History

Van Eck Associates Corp

$77.4 Billion
Q1 2025

A detailed history of Van Eck Associates Corp transactions in Intellia Therapeutics, Inc. stock. As of the latest transaction made, Van Eck Associates Corp holds 2,007 shares of NTLA stock, worth $26,311. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,007

Previous 2,188 8.27%

Holding current value

$26,311

Previous $26,000 46.15%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	SELL	$7.11 - $12.8 $1,286 - $2,316	-181 Reduced 8.27%	2,007 $14,000
Q4 2024 Jan 29, 2025	BUY	$11.41 - $21.09 $6,777 - $12,527	594 Added 37.26%	2,188 $26,000
Q3 2024 Oct 29, 2024	SELL	$19.72 - $27.36 $11,713 - $16,251	-594 Reduced 27.15%	1,594 $32,000
Q2 2024 Jul 31, 2024	BUY	$20.02 - $27.22 $1,701 - $2,313	85 Added 4.04%	2,188 $49,000
Q1 2024 Apr 30, 2024	BUY	$23.82 - $32.8 $3,835 - $5,280	161 Added 8.29%	2,103 $57,000
Q4 2023 Feb 05, 2024	BUY	$23.16 - $32.34 $7,573 - $10,575	327 Added 20.25%	1,942 $59,000
Q3 2023 Nov 08, 2023	SELL	$31.62 - $45.78 $2.62 Million - $3.8 Million	-82,927 Reduced 98.09%	1,615 $51,000
Q2 2023 Aug 03, 2023	BUY	$34.58 - $46.03 $25,277 - $33,647	731 Added 0.87%	84,542 $3.45 Million
Q1 2023 May 03, 2023	SELL	$33.3 - $44.82 $328,970 - $442,776	-9,879 Reduced 10.54%	83,811 $3.12 Million
Q4 2022 Feb 08, 2023	BUY	$33.21 - $62.69 $1.02 Million - $1.92 Million	30,589 Added 48.48%	93,690 $3.27 Million
Q3 2022 Oct 27, 2022	SELL	$53.92 - $71.7 $1.18 Million - $1.57 Million	-21,855 Reduced 25.73%	63,101 $3.53 Million
Q2 2022 Aug 03, 2022	BUY	$38.49 - $76.21 $258,960 - $512,740	6,728 Added 8.6%	84,956 $4.4 Million
Q1 2022 May 10, 2022	SELL	$58.27 - $118.99 $96,495 - $197,047	-1,656 Reduced 2.07%	78,228 $5.69 Million
Q4 2021 Jan 26, 2022	BUY	$100.76 - $138.36 $1.31 Million - $1.8 Million	13,010 Added 19.45%	79,884 $9.45 Million
Q3 2021 Nov 03, 2021	BUY	$132.37 - $176.78 $8.85 Million - $11.8 Million	66,874 New	66,874 $8.97 Million

Others Institutions Holding NTLA

# of Institutions

336

Shares Held

98.3M

Call Options Held

784K

Put Options Held

713K

View Full List

About Intellia Therapeutics, Inc.

Ticker NTLA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,011,800
Market Cap $997M
Description
Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...

More about NTLA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Van Eck Associates Corp, based on Form 13F filings with the SEC.

News

Stay updated on Van Eck Associates Corp with notifications on news.

Account

Van Eck Associates Corp Intellia Therapeutics, Inc. Transaction History